These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 31237944)

  • 1. Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.
    Brahmachari S; Lee S; Kim S; Yuan C; Karuppagounder SS; Ge P; Shi R; Kim EJ; Liu A; Kim D; Quintin S; Jiang H; Kumar M; Yun SP; Kam TI; Mao X; Lee Y; Swing DA; Tessarollo L; Ko HS; Dawson VL; Dawson TM
    Brain; 2019 Aug; 142(8):2380-2401. PubMed ID: 31237944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
    von Coelln R; Thomas B; Andrabi SA; Lim KL; Savitt JM; Saffary R; Stirling W; Bruno K; Hess EJ; Lee MK; Dawson VL; Dawson TM
    J Neurosci; 2006 Apr; 26(14):3685-96. PubMed ID: 16597723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration.
    Kim H; Shin JY; Jo A; Kim JH; Park S; Choi JY; Kang HC; Dawson VL; Dawson TM; Shin JH; Lee Y
    Brain; 2021 Dec; 144(12):3674-3691. PubMed ID: 34581802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson's Disease Etiopathology.
    Wilkaniec A; Lenkiewicz AM; Czapski GA; Jęśko HM; Hilgier W; Brodzik R; Gąssowska-Dobrowolska M; Culmsee C; Adamczyk A
    Mol Neurobiol; 2019 Jan; 56(1):125-140. PubMed ID: 29681024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin and defective ubiquitination in Parkinson's disease.
    Dawson TM
    J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration.
    Van Rompuy AS; Oliveras-Salvá M; Van der Perren A; Corti O; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2015 Jun; 10():23. PubMed ID: 26099628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease.
    Ganguly U; Banerjee A; Chakrabarti SS; Kaur U; Sen O; Cappai R; Chakrabarti S
    Biochem J; 2020 Mar; 477(6):1109-1122. PubMed ID: 32108853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.
    Shin JH; Ko HS; Kang H; Lee Y; Lee YI; Pletinkova O; Troconso JC; Dawson VL; Dawson TM
    Cell; 2011 Mar; 144(5):689-702. PubMed ID: 21376232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination increases parkin activity to promote autophagic α-synuclein clearance.
    Lonskaya I; Desforges NM; Hebron ML; Moussa CE
    PLoS One; 2013; 8(12):e83914. PubMed ID: 24386307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].
    Hattori N; Machida Y; Noda K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):905-7. PubMed ID: 16447759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson's disease, causes behavioral alterations but not neurodegeneration in mice.
    Ageta-Ishihara N; Yamakado H; Morita T; Hattori S; Takao K; Miyakawa T; Takahashi R; Kinoshita M
    Mol Brain; 2013 Aug; 6():35. PubMed ID: 23938054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models.
    Han R; Wang Q; Xiong X; Chen X; Tu Z; Li B; Zhang F; Chen C; Pan M; Xu T; Chen L; Wang Z; Liu Y; He D; Guo X; He F; Wu P; Yin P; Liu Y; Yan X; Li S; Li XJ; Yang W
    J Clin Invest; 2024 Oct; 134(20):. PubMed ID: 39403921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Animal models for familial Parkinson's disease].
    Takahashi R
    Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkin depletion delays motor decline dose-dependently without overtly affecting neuropathology in α-synuclein transgenic mice.
    Fournier M; Roux A; Garrigue J; Muriel MP; Blanche P; Lashuel HA; Anderson JP; Barbour R; Huang J; du Montcel ST; Brice A; Corti O
    BMC Neurosci; 2013 Nov; 14():135. PubMed ID: 24192137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.
    Panicker N; Kam TI; Wang H; Neifert S; Chou SC; Kumar M; Brahmachari S; Jhaldiyal A; Hinkle JT; Akkentli F; Mao X; Xu E; Karuppagounder SS; Hsu ET; Kang SU; Pletnikova O; Troncoso J; Dawson VL; Dawson TM
    Neuron; 2022 Aug; 110(15):2422-2437.e9. PubMed ID: 35654037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.
    Conway JA; Kinsman G; Kramer ER
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.